Compounds > fluorodeoxyglucose f18

Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Rhabdomyosarcoma 2

fluorodeoxyglucose f18 has been researched along with Rhabdomyosarcoma 2 in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (7.69)	18.2507
2000's	4 (30.77)	29.6817
2010's	6 (46.15)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Chavan, N; Datta, D; Kumar, R; Nalwa, A; Vaswani, S	1
Fujiwara, K; Ishida, H; Kanamitsu, K; Shimada, A; Tsukahara, H; Washio, K	1
Borrego-Dorado, I; de Bonilla-Damiá, A; Fernández-López, R; Márquez-Vega, C; Pachón-Garrudo, VM	1
Bielack, SS; Brossart, P; Dantonello, T; Dilloo, D; Feuchtgruber, S; Klingebiel, T; Koscielniak, E; Scheer, M; Schweigerer, L; Sparber-Sauer, M; Vokuhl, C; von Kalle, T	1
Bai, X; Wang, X	1
Yang, J; Zhen, L; Zhuang, H	1
Casey, DL; Dharmarajan, KV; Fox, JJ; Price, AN; Schoder, H; Wexler, LH; Wolden, SL	1
Chen, S; Dong, Y; Ma, C; Wang, S; Zhang, X	1
Goris, ML; Iagaru, A	1
Bar Shalom, R; Ben Arush, MW; Haimi, M; Israel, O; Militianu, D; Postovsky, S; Zaidman, I	1
Franc, B; Hetts, SW; Hilchey, SD; Wilson, R	1
Balan, KK; Seshadri, N; Wright, P	1
Al Suhaibani, H; Bakheet, SM; Ezzat, A; Powe, J; Rostom, A; Tulbah, A	1

Other Studies

13 other study(ies) available for fluorodeoxyglucose f18 and Rhabdomyosarcoma 2

Article	Year
18 F-FDG PET/CT of Alveolar Rhabdomyosarcoma of Prostate in a 17-Year-Old Boy. Clinical nuclear medicine, 2023, Jul-01, Volume: 48, Issue:7 Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Rhabdomyosarcoma, Alveolar	2023
A case of alveolar rhabdomyosarcoma showing concurrent responsive bone marrow lesions and refractory pancreatic lesions to pazopanib monotherapy. Pediatric blood & cancer, 2020, Volume: 67, Issue:9 Topics: Adolescent; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Forkhead Box Protein O1; Humans; Indazoles; Oncogene Proteins, Fusion; Paired Box Transcription Factors; Pancreatic Neoplasms; PAX3 Transcription Factor; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma, Alveolar; Sulfonamides; Tumor Microenvironment; Zoledronic Acid	2020
Medicina clinica, 2018, 02-23, Volume: 150, Issue:4 Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms	2018
Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging. Pediatric radiology, 2018, Volume: 48, Issue:5 Topics: Adolescent; Child; Child, Preschool; Contrast Media; Female; Fluorodeoxyglucose F18; Foot; Hand; Humans; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Whole Body Imaging	2018
Solitary Breast Metastasis From Rhabdomyosarcoma Shown on FDG PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:7 Topics: Adolescent; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar	2018
Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy. Clinical nuclear medicine, 2013, Volume: 38, Issue:12 Topics: Adult; Bone and Bones; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Tomography, X-Ray Computed	2013
Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography. International journal of radiation oncology, biology, physics, 2014, Dec-01, Volume: 90, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; ROC Curve; Treatment Outcome; Young Adult	2014
18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2017, Volume: 61, Issue:4 Topics: Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sensitivity and Specificity	2017
Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:9 Topics: Adolescent; Biopsy; Bone and Bones; Bone Marrow Neoplasms; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Technetium Tc 99m Medronate; Tomography, X-Ray Computed	2008
Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:7 Topics: Child, Preschool; Extremities; Fatal Outcome; Female; Fluorodeoxyglucose F18; Groin; Hand; Humans; Infant; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Remission Induction; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Survival Rate; Thigh; Tomography, X-Ray Computed; Treatment Outcome	2006
Case 110: Nonossifying fibroma. Radiology, 2007, Volume: 243, Issue:1 Topics: Adolescent; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Technetium; Thigh; Whole Body Imaging	2007
Rhabdomyosarcoma with widespread bone marrow infiltration: beneficial management role of F-18 FDG PET. Clinical nuclear medicine, 2007, Volume: 32, Issue:10 Topics: Adolescent; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar	2007
F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma. Clinical nuclear medicine, 1998, Volume: 23, Issue:9 Topics: Adolescent; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Phyllodes Tumor; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed	1998